Asset Dedication LLC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.27M | Buy |
9,004
+44
| +0.5% | +$9.47K | 0.14% | 103 |
|
|
2026
Q1 | $1.95M | Sell |
8,960
-1,756
| -16% | -$390K | 0.14% | 102 |
|
|
2025
Q4 | $2.45M | Sell |
10,716
-384
| -3% | -$87.5K | 0.16% | 90 |
|
|
2025
Q3 | $2.57M | Sell |
11,100
-680
| -6% | -$138K | 0.17% | 79 |
|
|
2025
Q2 | $2.19M | Buy |
11,780
+712
| +6% | +$132K | 0.16% | 89 |
|
|
2025
Q1 | $2.32M | Sell |
11,068
-758
| -6% | -$147K | 0.19% | 83 |
|
|
2024
Q4 | $2.1M | Sell |
11,826
-4,388
| -27% | -$807K | 0.17% | 85 |
|
|
2024
Q3 | $3.2M | Sell |
16,214
-4,162
| -20% | -$777K | 0.22% | 82 |
|
|
2024
Q2 | $3.49M | Sell |
20,376
-403
| -2% | -$66.8K | 0.24% | 82 |
|
|
2024
Q1 | $3.78M | Buy |
20,779
+8,713
| +72% | +$1.5M | 0.28% | 74 |
|
|
2023
Q4 | $1.86M | Sell |
12,066
-2,329
| -16% | -$340K | 0.15% | 109 |
|
|
2023
Q3 | $2.15M | Buy |
14,395
+1,120
| +8% | +$164K | 0.18% | 100 |
|
|
2023
Q2 | $1.8M | Sell |
13,275
-641
| -5% | -$94K | 0.15% | 111 |
|
|
2023
Q1 | $2.22M | Buy |
13,916
+514
| +4% | +$78.6K | 0.21% | 96 |
|
|
2022
Q4 | $2.17M | Buy |
13,402
+1,210
| +10% | +$186K | 0.22% | 90 |
|
|
2022
Q3 | $1.64M | Buy |
12,192
+379
| +3% | +$54.4K | 0.18% | 105 |
|
|
2022
Q2 | $1.81M | Buy |
11,813
+50
| +0.4% | +$7.64K | 0.27% | 66 |
|
|
2022
Q1 | $1.9M | Sell |
11,763
-2,195
| -16% | -$319K | 0.21% | 97 |
|
|
2021
Q4 | $1.89M | Buy |
13,958
+5,168
| +59% | +$610K | 0.23% | 96 |
|
|
2021
Q3 | $948K | Buy |
8,790
+1,712
| +24% | +$196K | 0.12% | 131 |
|
|
2021
Q2 | $796K | Buy |
7,078
+358
| +5% | +$40.3K | 0.12% | 138 |
|
|
2021
Q1 | $725K | Sell |
6,720
-438
| -6% | -$46.9K | 0.16% | 123 |
|
|
2020
Q4 | $768K | Sell |
7,158
-295
| -4% | -$28.3K | 0.15% | 127 |
|
|
2020
Q3 | $653K | Buy |
7,453
+544
| +8% | +$51.2K | 0.14% | 133 |
|
|
2020
Q2 | $677K | Sell |
6,909
-614
| -8% | -$54.1K | 0.18% | 117 |
|
|
2020
Q1 | $573K | Buy |
7,523
+1,287
| +21% | +$110K | 0.17% | 121 |
|
|
2019
Q4 | $552K | Buy |
6,236
+386
| +7% | +$32K | 0.16% | 123 |
|
|
2019
Q3 | $445K | Buy |
5,850
+1,646
| +39% | +$113K | 0.15% | 122 |
|
|
2019
Q2 | $306K | Sell |
4,204
-208
| -5% | -$16.3K | 0.1% | 136 |
|
|
2019
Q1 | $354K | Sell |
4,412
-13
| -0.3% | -$1.06K | 0.12% | 128 |
|
|
2018
Q4 | $408K | Sell |
4,425
-2,364
| -35% | -$208K | 0.17% | 116 |
|
|
2018
Q3 | $641K | Sell |
6,789
-391
| -5% | -$37.1K | 0.24% | 106 |
|
|
2018
Q2 | $666K | Sell |
7,180
-150
| -2% | -$14.6K | 0.23% | 105 |
|
|
2018
Q1 | $691K | Buy |
7,330
+751
| +11% | +$82.5K | 0.34% | 80 |
|
|
2017
Q4 | $634K | Buy |
6,579
+2,472
| +60% | +$233K | 0.26% | 99 |
|
|
2017
Q3 | $365K | Sell |
4,107
-138
| -3% | -$10.5K | 0.18% | 103 |
|
|
2017
Q2 | $307K | Sell |
4,245
-339
| -7% | -$22.8K | 0.15% | 117 |
|
|
2017
Q1 | $298K | Sell |
4,584
-90
| -2% | -$5.66K | 0.16% | 116 |
|
|
2016
Q4 | $294K | Buy |
4,674
+402
| +9% | +$24.5K | 0.17% | 115 |
|
|
2016
Q3 | $269K | Buy |
4,272
+100
| +2% | +$6.47K | 0.17% | 113 |
|
|
2016
Q2 | $259K | Sell |
4,172
-834
| -17% | -$50.8K | 0.18% | 110 |
|
|
2016
Q1 | $286K | Sell |
5,006
-389
| -7% | -$21.7K | 0.21% | 104 |
|
|
2015
Q4 | $320K | Buy |
+5,395
| New | +$311K | 0.21% | 108 |
|
Other funds holding ABBV
Asset Dedication LLC's ABBV Position: Q2 2026 in Review
Asset Dedication LLC increased its AbbVie (ABBV) stake by 0.49% in Q2 2026, buying an estimated $9.47K and bringing the position to 9,004 shares worth $2.27M. The position accounts for 0.14% of the portfolio, ranked #103.
Asset Dedication LLC first reported a position in ABBV in Q4 2015 and has held it in 43 quarters since. The position peaked at $3.78M in Q1 2024. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Asset Dedication LLC held 9,004 shares of AbbVie worth $2.27M as of Q2 2026.
- Asset Dedication LLC bought 44 AbbVie shares in Q2 2026, an estimated $9.47K.
- AbbVie made up 0.14% of Asset Dedication LLC's portfolio in Q2 2026, its #103 holding.
- Asset Dedication LLC first reported a position in AbbVie in Q4 2015 and has held it in 43 quarters since.
- Asset Dedication LLC's AbbVie position peaked at $3.78M in Q1 2024.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.